K. Lucas

1.4k total citations · 3 hit papers
13 papers, 528 citations indexed

About

K. Lucas is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, K. Lucas has authored 13 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in K. Lucas's work include Liver Disease Diagnosis and Treatment (4 papers), Fibroblast Growth Factor Research (2 papers) and Diet and metabolism studies (2 papers). K. Lucas is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Fibroblast Growth Factor Research (2 papers) and Diet and metabolism studies (2 papers). K. Lucas collaborates with scholars based in United Kingdom, United States and Malta. K. Lucas's co-authors include Guy Neff, Stephen A. Harrison, Dominic Labriola, Rebecca Taub, Naim Alkhouri, Mustafa R. Bashir, Doreen Chan, Erik J. Tillman, Tim Rolph and Andrew Cheng and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

K. Lucas

13 papers receiving 520 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial

2023 234 citations Stephen A. Harrison, Rebecca Taub et al. Nature Medicine profile →
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

2023 146 citations Stephen A. Harrison, Juan P. Frías et al. The Lancet. Gastroenterology & hepatology profile →
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH

2025 19 citations Mazen Noureddin, Mary E. Rinella et al. New England Journal of Medicine profile →

Peers

K. Lucas

EPIDE

EDM

MB

HEPAT

PHYSI

Alexia Rouland France

Philip Home United Kingdom

R Casamitjana Spain

Lijing Jia China

Tzu‐Hao Li Taiwan

Ran Cui China

Eva Martin‐Solana Spain

Felipe David Mendonça Chaim Brazil

Steve Hurel United Kingdom

Alexia Rouland France

K. Lucas

293 ×0.9

EPIDE

290 ×1.1

EDM

128 ×1.3

MB

104 ×1.2

HEPAT

100 ×1.4

PHYSI

Citations per year, relative to K. Lucas K. Lucas (= 1×) peers Alexia Rouland

Countries citing papers authored by K. Lucas

Since Specialization

Citations

This map shows the geographic impact of K. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Lucas more than expected).

Fields of papers citing papers by K. Lucas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Lucas. The network helps show where K. Lucas may publish in the future.

Co-authorship network of co-authors of K. Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of K. Lucas. A scholar is included among the top collaborators of K. Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Lucas. K. Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Noureddin, Mazen, Juan P. Frías, Guy Neff, et al.. (2025). Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. 406(10504). 719–730. 5 indexed citations

2.

Noureddin, Mazen, Mary E. Rinella, Naga Chalasani, et al.. (2025). Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. New England Journal of Medicine. 392(24). 2413–2424. 19 indexed citations breakdown →

3.

Lucas, K., et al.. (2024). Evaluating Large Language Models in Detecting Test Smells. 672–678. 5 indexed citations

4.

Harrison, Stephen A., Juan P. Frías, Guy Neff, et al.. (2023). Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. Gastroenterology & hepatology. 8(12). 1080–1093. 146 indexed citations breakdown →

5.

Harrison, Stephen A., Rebecca Taub, Guy Neff, et al.. (2023). Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nature Medicine. 29(11). 2919–2928. 234 indexed citations breakdown →

6.

Otter, Simon, K. Lucas, Kate Springett, et al.. (2012). Identifying Patient‐Reported Outcomes in Rheumatoid Arthritis: The Impact of Foot Symptoms on Self‐Perceived Quality of Life. Musculoskeletal Care. 10(2). 65–75. 16 indexed citations

7.

Formosa, Cynthia, Anne Mandy, & K. Lucas. (2011). Identifying changes in diabetes care. Practical Diabetes International. 28(1). 31–34. 2 indexed citations

8.

McInnes, Alistair, William Jeffcoate, Loretta Vileikytė, et al.. (2010). Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabetic Medicine. 28(2). 162–167. 64 indexed citations

9.

Otter, Simon, K. Lucas, Kate Springett, et al.. (2010). Comparison of foot pain and foot care among rheumatoid arthritis patients taking and not taking anti-TNFα therapy: an epidemiological study. Rheumatology International. 31(11). 1515–1519. 21 indexed citations

10.

Vogel, Steven, et al.. (2008). Exploring the use of exercise therapy in UK osteopathic practice. International journal of osteopathic medicine. 11(4). 164–164. 4 indexed citations

11.

Lucas, K. & Graham Bickler. (2000). Altogether now? Professional differences in the priorities of primary care groups. Journal of Public Health. 22(2). 211–215. 8 indexed citations

12.

Lucas, K. & B Lloyd. (1999). Does smoking help adolescents cope with stress. Figshare. 1 indexed citations

13.

Lucas, K., Dennis G. Karounos, George J. Ellis, et al.. (1986). The intravenous insulin tolerance test in type I diabetes.. PubMed. 53(3). 331–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact